Skip to main content
VALIRX PLC logo

VALIRX PLC — Investor Relations & Filings

Ticker · VAL ISIN · GB00BLH13C52 LEI · 213800VQKB9SJCQDET40 IL Professional, scientific and technical activities
Open in API
Filings indexed 574 across all filing types
Latest filing 2015-05-27 Regulatory Filings
Country GB United Kingdom
Listing IL VAL

About VALIRX PLC

https://www.valirx.com/

ValiRx PLC is a life science company that accelerates the development of therapeutics and diagnostics, with a primary focus on oncology and women's health. The company's business model centers on identifying and progressing promising early-stage scientific discoveries through pre-clinical and clinical development. ValiRx provides scientific, financial, and commercial expertise to translate novel research into clinically validated treatments, aiming to improve patient outcomes in its target therapeutic areas.

Recent filings

Filing Released Lang Actions
Stmnt re Share Price Movement
Regulatory Filings Classification · 1% confidence The document is very short (1109 characters) and begins with an 'RNS Number'. It is a brief statement from ValiRx Plc addressing a recent increase in the company's share price, confirming they are unaware of any specific reason for the movement. This type of immediate, non-periodic, general corporate announcement that is distributed via the London Stock Exchange's news service (RNS) and does not fit into specific categories like earnings, dividends, or director dealings, is best classified as a general Regulatory Filing or announcement. Given the options, 'RNS' (Regulatory Filings) is the most appropriate fallback category for miscellaneous regulatory announcements that don't fit elsewhere.
2015-05-27 English
Result of AGM and Capital Reorganisation
AGM Information Classification · 1% confidence The document is an RNS announcement (indicated by 'RNS Number : 3669N' and the closing 'This information is provided by RNS'). The title explicitly states 'RESULT OF ANNUAL GENERAL MEETING AND CAPITAL REORGANISATION'. Since it reports the results of the AGM ('all resolutions were duly passed') and details a significant capital structure change (consolidation and sub-division), it covers two key areas: AGM results and Capital/Financing updates. However, the primary context is the outcome of the shareholder meeting, which directly relates to voting results. The 'Declaration of Voting Results & Voting Rights Announcements' (DVA) covers official results from shareholder votes at any general meeting. While it also discusses capital reorganization (CAP), the announcement is framed around the AGM outcome. Given the dual nature, DVA is a strong fit for the voting result, and CAP is a strong fit for the reorganization. Since the document explicitly states the AGM results were passed, DVA is highly relevant. Furthermore, the capital reorganization is a direct consequence of resolutions passed at the AGM. I will prioritize the AGM result aspect as the primary driver for classification, but acknowledge the strong capital component. Since the document details the outcome of the AGM resolutions, DVA is the most precise fit among the options covering meeting outcomes. If DVA were not available, CAP or RNS would be considered. Given the explicit mention of 'RESULT OF ANNUAL GENERAL MEETING', DVA is the best fit.
2015-05-15 English
Notification of US Patent Grant Allowance reVAL401
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated May 14, 2015. The content announces a 'Notification of US Patent Grant Allowance for VAL401' related to a joint venture's cancer treatment. This type of announcement, which communicates specific, material, non-financial corporate news via the Regulatory News Service (RNS) system of the London Stock Exchange, fits the definition of a general regulatory announcement that doesn't fit a more specific category like ER, DIV, or DIRS. Since it is a formal notification distributed through the RNS system, the most appropriate classification is Regulatory Filings (RNS). The document length is moderate (5055 chars), but the key identifier is the RNS header and the nature of the announcement (patent grant notification).
2015-05-14 English
ValiSeek Development Update
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory announcement disseminated via the London Stock Exchange's Regulatory News Service (RNS). The content provides a 'Development Update' on a drug (VAL401) progress, including completion of pre-clinical studies, regulatory planning with the MHRA, and upcoming convention attendance. This is not a full financial report (like 10-K or IR), nor is it a management change (MANG) or dividend notice (DIV). It is a general, material update released through the official regulatory channel. Since it is a specific operational/development update disseminated via RNS, and does not fit perfectly into categories like LTR (Legal) or CAP (Financing), the most appropriate classification is the general regulatory announcement category, RNS, as per the definition: 'General regulatory announcements and fallback category for miscellaneous filings that do not neatly fit into other specific categories.' The document length (6891 chars) is substantial enough that it is the primary announcement itself, not just a notice of publication (RPA).
2015-05-14 English
Re Contract
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 4159M' and concludes with 'This information is provided by RNS' and 'END CNTUNVNRVSAVRAR'. RNS stands for Regulatory News Service, which is a primary channel for official announcements to the London Stock Exchange. The content is a press release announcing a new contract secured by ValiRx Plc regarding its TRAC technology. This type of material—a general, timely announcement of a business event that doesn't fit neatly into specific financial reporting categories like 10-K, ER, or DIV—is best classified as a general Regulatory Filing or announcement, which corresponds to the RNS code in the provided definitions.
2015-05-07 English
Notice of AGM and Proposed Capital Reorganisation
Share Issue/Capital Change Classification · 1% confidence The document is an RNS announcement (indicated by 'RNS Number : 9102K' and the closing statement 'This information is provided by RNS'). The primary subject is the 'NOTICE OF ANNUAL GENERAL MEETING AND PROPOSED CAPITAL REORGANISATION'. It explicitly mentions that the Annual Report and Accounts, along with the Notice of AGM, 'will be posted to shareholders later today'. Since the document itself is an announcement detailing the AGM date and proposing a capital reorganisation (which falls under 'CAP' or 'SHA'), but its main function is to inform the market about the upcoming AGM and the associated documents, it strongly relates to the AGM process. The key components are the AGM notice and the Capital Reorganisation details. The Capital Reorganisation (consolidation and sub-division of shares) directly relates to 'SHA' (Share Issue/Capital Change) or 'CAP' (Capital/Financing Update). However, the document is framed as the official notice for the AGM where these proposals will be voted on. Given the dual nature, we must choose the most encompassing or primary regulatory event. The document explicitly mentions the 'Notice of Annual General Meeting' and provides the date/location. The capital reorganisation is a proposal to be considered at the AGM. Since the document is an announcement about the AGM and related proposals, and it is not the full Annual Report (10-K) or a standalone Audit Report (AR), 'AGM-R' (AGM Information) is a strong candidate, as it contains the notice. However, the detailed description of the share consolidation/sub-division is a significant capital structure event. Since the document is an announcement detailing a major capital change (Consolidation/Sub-Division) that requires shareholder approval at the AGM, 'CAP' (Capital/Financing Update) is highly relevant. Given the explicit mention of 'PROPOSED CAPITAL REORGANISATION' and the detailed mechanics of the share consolidation/sub-division, 'CAP' is the most specific classification for the core financial action being announced, even though it is delivered via the AGM notice mechanism. The document is short enough (7580 chars) that it is an announcement, not the full report. I will classify it as CAP due to the detailed capital reorganisation proposal, which is a primary focus alongside the AGM notice.
2015-04-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.